Phase 3 Clinical Study of AK112 for NSCLC Patients

Clinical trial NCT05184712 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05184712
Sponsor: Akeso
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Squamous Non-small Cell Lung Cancer

Start date: 2022-01-25
Primary completion: 2023-03-10
Enrollment: 322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.